BRUSSELS, BELGUIM — On July 14, Mars Petcare appointed Nefertiti Greene to president of the company’s new division: Science & Diagnostics. Beginning July 18, Greene will direct the new division, expanding its business into pet diagnostics and science, as well as supporting its Waltham Petcare Science Institute.

The new Science & Diagnostics division will work across multiple areas of pet care, including data science, dog and cat microbiomes, health and disease biomarkers and pet nutrition to develop advanced health and wellness care products. The new division builds upon Mars Petcare’s pet biobank, which launched in June 2022.

“Nefertiti will play an integral role in the continued growth of our diagnostics business and accelerate the impact of our science,” said Loic Moutault, president of Mars Petcare Global. “We’re very proud of our diagnostics business, which has a central role in the broader Mars Petcare ecosystem as an important way we deliver on our purpose.  And we recognize that shifting from curative to preventative veterinary care depends on being able to accurately predict and diagnose disease in pets.” 

Prior to Mars Petcare, Greene served as head of enterprise strategy and chief of staff at business giant Johnson & Johnson. She has also served as US president and global president for Ethicon, Inc., president of Janssen Therapeutics, and US division head for diabetes at Bayer. Greene began her career at Regeneron, focusing on scientific research, marketing and commercial operations.

Greene has nearly 30 years of experience in general management, commercial operations and clinical research in the pharmaceutical and medical technology industries.

Along with an extensive career, Greene has served as an executive advisor for the Enterprise Veterans Leadership Council, a member of the North American Diversity, Equity and Inclusion board, and is currently a member of the Executive Leadership Council. She has also been recognized by the National Association of Female Executives (NAFE) as P&L Leader of the Year.

“I am excited to join the Mars Petcare leadership team and look forward to using my experience in the healthcare industry to help build on the successes in diagnostics and science at Mars Petcare,” Greene said. “As a pet owner I’m looking forward to helping further the reach and impact of diagnostics and science for pets around the world.”    

Read more about personnel changes throughout the industry.